TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Sequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2-/- microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2 impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated by microglia. Moreover, migration towards defined chemo-attractants is reduced upon ablation of TREM2 and can be rescued by TREM2 re-expression. In vivo, microglia lacking TREM2 migrate less towards injected apoptotic neurons, and outgrowth of microglial processes towards sites of laser-induced focal CNS damage in the somatosensory cortex is slowed. The apparent lack of chemotactic stimulation upon depletion of TREM2 is consistent with a stable expression profile of genes characterizing the homoeostatic signature of microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2-mediated signaling is known to inhibit the transition of microglia to a more Disease-Associated Microglia (DAM) state characterized by enhanced migration, chemotaxis, and phagocytosis [44,45].”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, lack of Trem2 reduces chemotaxis and phagocytosis of microglia (54, 55).”
From Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis (2021) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglia with TREM2 loss-of-function cannot transition to the DAM state and are locked in a homeostatic state, in which they no longer respond normally to pathological challenges [34].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“compelling evidence suggesting that TREM2 can regulate microglia phagocytic activity [44,45]”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 is a cell-surface receptor of the immunoglobulin superfamily implicated in a variety of microglial functions, such as phagocytosis, chemotaxis and survival21–23.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 2×
“The migration distance was measured using Fiji [65] by drawing a line between the migrated cell and the slice culture border.”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“However, the most commonly shared pathological principle of basically all neurodegenerative diseases and many other neurological disorders is gliosis associated with an inflammatory response [4].”
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“In the WT-and Trem2-deficient offspring, we induced a focal CNS damage in the somatosensory cortex using a focussed laser beam [45 – 47] and acquired time-lapse images of the microglial response using in vivo two-photon microscopy (Fig 5A).”
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Furthermore, for several neurodegenerative diseases, evidence exists that soluble oligomers, which may be rather stable intermediates of the aggregation process of amyloidogenic proteins, are the executers of neurotoxicity [2].”
Self-citationSynaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“Microglia are the resident macrophages of the central nervous system and play a pivotal role in synaptic pruning and apoptotic cell clearance during development of the nervous system [51 – 56].”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 1×
“As the innate immune cells of the brain, microglia are the first cells to respond to neuronal damage [16,41].”
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Cited by
Items 301–355 of 355
TREM2 and calcium signaling in microglia – is it relevant for Alzheimer's disease?
Gerasimov, E., Pchitskaya, E. I., & Борисович, Б. И. (2022) · Cell Calcium · doi:10.1016/j.ceca.2022.102584
TREM2 limits progression of deficits and spreading of tau pathology in micePreprint
Feiten, A., Au, C. G., Sabale, M., van Hummel, A., van der Hoven, J., Deng, Y., Przybyla, M., Bright, F., Butler, T., Delerue, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-741896/v2
Investigação do papel da Microglia derivada de iPSC no Transtorno do Espectro do Autismo.
Castanha, A. G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2022.tde-18042022-145828
Research Progress on the Role of DAP12 Mediated Microglia Activation in Nervous System
张, 童. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121728
Additional file 7 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160927
Additional file 6 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160924
Additional file 5 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160921
Additional file 8 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160930
Le, L., Eliseeva, S. I., Kara-Pabani, K., Li, H., Yarovinsky, F., & Majewska, A. K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4795163
Zhang, C., Wang, H., Hong, S.-H., Yan, R., & Shin, D. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-82768-6_23
de Weerd, L., Hummel, S., Müller, S. A., Paris, I., Sandmann, T., Eichholtz, M., Gröger, R., Englert, A. L., Wagner, S., Ha, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.10.645950
Self-citationFluid and Imaging Markers of Glial Reactivity
Suárez‐Calvet, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_6 · Cited by 1
Ismail, N. M., Miller, M. A., Crossland, H., Phillips, B. E., Sharif, J.-A., Kosanovic, C., Gu, T., Brogan, R. J., Wahlestedt, C., Atherton, P. J., et al. (2025) · medRxiv · doi:10.1101/2025.10.02.25337067
“TREM2 , essential for microglial activation, metabolism, phagocytosis, CNS immune response, and overall brain homeostasis, has an established role in AD progression [74,75], with AD patients displaying increased TREM2 levels [76,77].”
Additional file 1 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160909
Additional file 4 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160918
Additional file 10 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160897
Additional file 11 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160900
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829558
Self-citationYan, Y., Bai, S., Han, H., Dai, J., Niu, L., Wang, H., Dong, Q., Yin, H., Yuan, G., & Pan, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26720916
Additional file 3 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160915
Franzmeier, N., Suárez‐Calvet, M., Frontzkowski, L. K., Moore, A. M., Hohman, T. J., Morenas‐Rodríguez, E., Nuscher, B., Shaw, L. M. J., Trojanowski, J. Q., Dichgans, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13071124
Self-citationAdditional file 2 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160912
Domowicz, M. S., Chan, W.-C., Vázquez, P. N. C., Gonzalez, T., & Schwartz, N. B. (2021) · Figshare · doi:10.6084/m9.figshare.16960276
Claes, C., Danhash, E., Hasselmann, J., Chadarevian, J. P., Shabestari, S. K., England, W., Lim, T. E., Hidalgo, J. L. S., Spitale, R. C., Davtyan, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15047551
Zatcepin, A., Gnörich, J. S., Rauchmann, B.-S., Bartos, L. M., Wagner, S., Franzmeier, N., Malpetti, M., Xiang, X., Shi, Y., Parhizkar, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26952306
Self-citationAdditional file 9 of Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V., Lin, P. B., Pennington, T., Prisco, G. V. D., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13160933
Pesämaa, I., Müller, S. A., Robinson, S., Darcher, A., Paquet, D., Zetterberg, H., Lichtenthaler, S. F., & Haass, C. (2024) · Figshare · doi:10.6084/m9.figshare.24223891
Self-citationJoshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829555
Self-citationGnörich, J. S., Reifschneider, A., Wind, K., Zatcepin, A., Kunte, S. T., Beumers, P., Bartos, L. M., Wiedemann, T., Grosch, M., Xiang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571058
Self-citationFrieß, L., Cheray, M., Keane, L., Grabert, K., & Joseph, B. (2021) · Figshare · doi:10.6084/m9.figshare.14728529
Transport vehicle–mediated TREM2 PET maps myeloid cells in the glioblastoma microenvironmentPreprint
Brendel, M., Bartos, L. M., Feng, R., Mueller, K., Koessinger, A. L., Teske, N. C., Greve, T., Kirchleitner, S. V., Blobner, J., Nikolaishvili, E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8627080/v1
Self-citationCasavilca-Zambrano, S. A., Custodio, N., Liendo-Picoaga, R., Mancilla, J. J. C., Bonifacio-Mundaca, J., Montesinos, R., Fejerman, L., Zavala, V. A., Bertani, S., Honles, J., et al. (2026) · The Oncologist · doi:10.1093/oncolo/oyag058
“56,57 73 Ancestry plays a key role in the frequency of risk alleles.”
Introduction to microglial aging and its involvement in neurodegenerative diseases
Ben-Azu, B., Gargus, M., Verkhratsky, A., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00007-3 · Cited by 1
Amyloid Beta Revisited: A Versatile Immune PolypeptidePreprint
Slama, P. S. (2026) · Qeios · doi:10.32388/2esvyp
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Étude de l’influence de la glutaminolyse des macrophages dans les maladies cardio-métaboliques
Merlin, J. (2020) · theses.fr (ABES) · doi:10.70675/68e10f28zf840z48bfz9bacz5511a3a2b208
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
Impact de la consommation de fructose sur la microglie et la santé cérébrale
Coursan, A. (2024) · theses.fr (ABES) · doi:10.70675/c509f961z7098z4c0bz92b0z8ba14be2e725
Amyloid Beta Revisited: A Versatile Immune PolypeptidePreprint
Slama, P. S. (2026) · Qeios · doi:10.32388/2esvyp.2
Hall‐Roberts, H., Maguire, E., Shaw, B., O’Donoghue, R., Winston, J., Keat, S., Capitani, L., Mahoney, R., Geary, B., Faber, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.721607
“…measures of mitochondrial function, inflammatory cytokine secretion, lipid accumulation, calcium store release, endocytic uptake, phagocytosis, and chemotaxis (Maguire et al., 2021, 2022; Maninger et al., 2024; Mazaheri et al., 2017; Muth et al., 2019; Piers et al., 2019; Victor et al., 2022).”
Barros, T. G. R., Grossi, L. B., Campos, M. L. D. S., Cardoso, I. B.-H. N., Teixeira, A. L., de Miranda, A. S., & Toscano, E. C. D. B. (2026) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70077
A CSF disease-associated macrophage signature defines progressive multiple sclerosis
Börsch, A., Riethues, F., Schulte‐Mecklenbeck, A., Wang, X., Heming, M., Lu, I., Müller‐Miny, L., Wiendl, H., Groß, C. C., Bernard‐Valnet, R., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03861-9
Microenvironmental Regulation of Central Nervous System Myelination and Remyelination
Wang, Y., Tan, L., Lao, L., Huang, X., Zhang, S., & Sun, H. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43257 · Cited by 1
Sha, L., & Jha, S. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.04.008
Shirotani, K., Hatta, D., Watanabe, K., Saito, T., Saido, T. C., & Iwata, N. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115894 · Cited by 1
Wang, H., Wen, R., Parker, E., & Yang, L. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03083-9 · Cited by 4
“This inhibition can restore microglial homeostasis in APP-PS1 and SOD1 mice, but blocks the microglia’s defensive functions during disease progression [83].”
Shirotani, K., Hatta, D., Watanabe, K., Saito, T., Saido, T. C., & Iwata, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.724708
“…such as cytokine production, migration, proliferation, cell survival, phagocytosis, compaction of amyloid plaques and synapse elimination (Filipello et al., 2018; Jay et al., 2017, 2015; Mazaheri et al., 2017; Takahashi et al., 2005; Ulrich et al., 2014; Wang et al., 2016, 2015; Yuan et al., 2016).”
Yang, G., Xu, X., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1893545 · Cited by 1
“…display impaired chemotaxis toward ATP gradients, reduced capacity to compact A b deposits, and a propensity to accumulate lipid droplets and cholesteryl esters when challenged with myelin debris, phenotypes that echo, in milder form, the profound defects seen in TREM2 or TYROBP null mutants (109).”
Debray, H. Z., Cheng, D., Ayala, L. A., Lam, T., Shin, J., Nicholas, D., Inlay, M. A., Drayman, N., Edwards, R. A., & Lodoen, M. B. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014462
“TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) is a cell-surface immunoreceptor that binds to anionic ligands and contributes to a variety of immune functions, including phagocytosis, chemotaxis, and cellular survival [14,15].”
Peng, Y., Jin, C. J., Sun, Y., Mu, W., & Zheng, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898176
Revisiting the role of amyloid-β: A molecular and immunological perspective
Slama, P. S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261484863
“125,126 TREM2 variants that favor the proper removal of oligomers would thus be bene fi cial against these A β -metal oligomers (see ApoE section, below).”
The Role of the Mammalian Target of Rapamycin in Microglial Phenotypic Polarization
Partridge, K. J., & Ebert, A. D. (2026) · Cells · doi:10.3390/cells15181654
“For example, during embryonic and early postnatal development, microglia exhibit pronounced heterogeneity, adopting specialized phenotypes that support neurodevelopmental processes such as synapse refinement and circuit formation [18–20].”
The microglial lineage: from molecular states to context-dependent functions
Li, C., Wu, Z., Xiang, X., & Li, H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100378
“After middle-cerebral-artery occlusion (MCAO), TREM2 deficiency impairs chemotaxis or phagocytic activity and worsens neurological outcome (Kawabori et al., 2015; Mazaheri et al., 2017).”
Dejanovic, B., Figley, M. D., Weisman, E. F., Kiragasi, B., Gergits, F. W., Larson, K., Renoux, A. J., Rajagovindan, R., Pandya, B. A., Houze, J. B., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec5740 · Cited by 2
Sandmann, T. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.14812454
Metadata
- Authors
- Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., Brunner, B., Bultmann, S., Tahirovic, S., Kerschensteiner, M., Misgeld, T., Butovsky, O., & Haass, C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- Brigham and Women's Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Helmholtz Munich (DE)
- Center for Integrated Protein Science Munich (DE)
- Corresponding author
- Haass, Christian
- ORCID
- Venue
- The EMBO Reports
- Published
- 2017-05-08
- Volume
- 18
- Issue
- 7
- Pages
- 1186-1198
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC5494532
- OpenAlex
- W2612288104
- Cited by
- 351
- References
- 69
- Citations by year
- 2026: 37 · 2025: 34 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 41 · 2020: 44 · 2019: 34 · 2018: 36 · 2017: 10
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (EXC 1010, Mi 694/4‐1(SPP1710)/7‐1/8‐1)
- European Union's Seventh Framework Program (FP7/2007–2013)
- ERC (321366, 616791)
- Cure Alzheimer's
- Center for Integrated Protein Science Munich (EXC 114)
- Hans‐and‐Ilse‐Breuer Foundation
- German Science Foundation Collaborative Research Centre (870)
- Helmholtz Portfolio Theme “Supercomputing and Modeling for the Human Brain”
- NIH‐NINDS (1R01NS088137)
- NIA (1R01AG051812)
- National Multiple Sclerosis Society (5092A1)
- Amyotrophic Lateral Sclerosis Association (ALSA2087)
- Nancy Davis Foundation
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, microglia, chemotaxis, microglial migration, neuronal injury, loss of function, microglial transcriptome, Alzheimer's disease, frontotemporal lobar degeneration, somatosensory cortex, neurodegeneration
- MeSH terms
- Loss of Function Mutation, Alzheimer Disease, Cells, Cultured, Chemotaxis, Humans, Membrane Glycoproteins, Neurons, Phagocytosis, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Gene Expression Profiling, Myeloid Cells, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.